4//SEC Filing
Sherman Matthew L 4
Accession 0001209191-23-051886
CIK 0001654151other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 4:05 PM ET
Size
4.8 KB
Accession
0001209191-23-051886
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-10-02$12.68/sh−2,942$37,305→ 84,744 total
Footnotes (1)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001325710
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 4:05 PM ET
- Size
- 4.8 KB